查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1850553

週边血管器械市场按产品类型、技术类型、材料类型、适应症、患者类型和最终用户划分－2025-2032年全球预测

Peripheral Vascular Devices Market by Product, Technology Type, Material Type, Indication, Patient Types, End-User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，週边血管器械市场规模将达到 237.2 亿美元，复合年增长率为 6.19%。

主要市场统计数据
基准年 2024 146.6亿美元
预计年份：2025年 155亿美元
预测年份：2032年 237.2亿美元
复合年增长率 (%) 6.19%

本文重点介绍临床实务、设备创新和卫生系统管理的机会和挑战。

週边血管介入器械正处于人口老化、疾病负担变化和手术技术快速创新交汇的阶段。临床医生越来越依赖各种器械，从微创导管介入到开放式外科移植。手术方式的多样化促使人们需要整合临床路径，以优化患者预后并控製成本。因此，医院系统和门诊手术中心正在重新审视器械配方、器械采用标准和库存策略，以在常规血管介入治疗中平衡疗效和可重复性。

同时，不断变化的监管法规正在重新定义证据阈值和上市后监测预期，促使製造商投资于更早期、更可靠的临床数据，并采用考虑产品生命週期的迭代式设备设计。从支付方的角度来看，基于价值的报销结构和手术环境的转变，正在创造新的奖励，促使他们优先选择那些能够显着降低再入院率、手术併发症和缩短功能恢復时间的设备。所有这些因素共同作用，使得临床领导者、设备开发人员和医疗系统采购者之间的跨领域合作至关重要，才能将创新转化为可扩展的医疗服务改进。

展望未来，能够协调临床证据、生产灵活性和报销资讯的公司将获得策略优势，从而满足临床医生的偏好和医疗保健提供者的采购标准。

全面审视正在改变週边血管护理临床实践、技术应用和竞争动态的变革性转变。

週边血管器材的临床应用格局正经历多重同步转变，重塑其应用模式与竞争格局。微创技术正持续拓展应用范围，惠及以往接受开放性手术的患者群，主要得益于导管设计、斑块修復技术和支架材料的改进。术中影像和导航技术的进步也推动了这一趋势，提高了手术精准度，并扩大了血管内治疗的适应症范围。随着临床医生和医疗系统倾向于选择创伤更小、能够加快康復速度并减少住院次数的治疗途径，製造商在设计下一代解决方案时，必须优先考虑易用性、互通性和可靠的临床疗效。

同时，材料科学的进步使人们重新关注医疗器材的长期生物相容性和耐久性。某些器械材料转向镍钛合金、钴铬合金、聚合物涂层和混合材料，反映出製造商致力于优化径向强度、输送性和内皮化特性。法律规范和支付方越来越重视安全讯号和实际应用效果，迫使医疗设备製造商将上市后证据的产生纳入其产品策略。此外，随着相关人员寻求提高前置作业时间和库存的透明度并降低中断风险，对供应链韧性和在地化生产的投资正成为策略重点。

总而言之，这些变革性的转变凸显了以证据为导向的商业化方法的重要性，这种方法将临床效用与可扩展的生产和分销模式相结合。

分析探讨2025年美国关税如何影响医疗设备製造商的供应链结构、筹资策略和商业营运。

2025年实施的关税调整迫使设备製造商和经销商重新评估其全球采购布局和製造外包伙伴关係。虽然关税针对的是特定原材料和成品，但其更广泛的影响正在加速对近岸外包机会、双重采购条款以及关键零件生产的垂直整合的评估。製造商越来越多地采用总到岸成本模型，该模型考虑了关税和运费波动以及库存持有成本，以帮助他们做出供应商选择和资本投资决策。因此，设备开发人员优先考虑那些能够提供地理多样性、品质稳定性和根据需求波动灵活调整生产规模的供应商关係。

监管註册时限和进口合规要求也在影响企业的市场准入策略。依赖跨国供应链的企业必须应对额外的行政复杂性以及可能延长的前置作业时间，尤其对于包含复杂多组件的设备而言更是如此。因此，采购团队正在修订合约条款，增加海关紧急条款，并加强与海关和贸易合规专业人员的合作，以维护利润空间。对于规模较小的创新企业而言，海关环境使得与已合规且拥有多元化供应链的成熟製造商达成许可协议和战略合作伙伴关係更具吸引力。

总而言之，2025 年的关税状况​​为将重点转移到韧性和成本透明度上提供了一个切实的机会，鼓励对供应链可视性、替代采购和更具抗贸易政策波动能力的製造策略进行投资。

将产品类别、手术技术、材料、临床适应症、患者群体和终端用户环境等方面的细分洞察进行详细整合，以指导有针对性的商业化策略。

产品层面的异质性决定了临床和采购相关人员如何评估週边血管产品。市场涵盖球囊扩张装置、各种导管类型、移植物、导管导引线、下腔静脉滤器、导引器、斑块修饰装置、支架和血管闭合系统。在导管方面，长导管、中线导管和短导管之间的差异会影响手术方案的选择、库存管理和临床医生培训的重点。移植物的选择反映了材料和生物学的考虑，生物移植物、发泡聚四氟乙烯移植物和聚酯移植物各自具有独特的操作特性和长期性能权衡。支架技术进一步分为球囊扩张式和自扩张式，临床医师根据病变形态、血管大小和输送需求进行选择。

技术类型细分市场主要区分微创手术和开放手术。斑块的可输送性、影像相容性和斑块修饰辅助工具是优先考虑的因素，尤其对于血管成形术和支架植入术等微创治疗方法而言更是如此。相反，搭桥手术和置入术等开放性手术则需要可靠的移植物选择、灌注方面的考量以及专用器械。金属和非金属器械的材料差异决定了器械的选择，主要体现在径向强度、抗疲劳性和生物相容性等方面。金属器械的亚型包括钴铬合金、镍钛合金和不銹钢，而非金属器械则包括聚合物和硅基材料，并采用不断发展的涂层技术。

依临床适应症和患者类型进行细分也会影响商业性优先事项。适应症涵盖功能性週边血管疾病，如慢性静脉功能不全、雷诺氏症和静脉曲张，以及阻塞性疾病，如动脉粥状硬化、血栓闭塞性脉管炎、颈动脉疾病、深层静脉栓塞症和淋巴水肿。患者类别包括按急性或慢性疾病区分的成人和老年人群，以及患有后天性或先天性疾病的儿童群体。终端使用者环境，例如门诊手术中心、门诊诊所和医院，各自有不同的采购週期、法律规范和对临床医生能力的要求。整合这些细分视角，能够帮助企业将产品设计、临床证据产生和上市模式与目标临床管道和医疗保健采购方的需求相匹配。

深入了解全球主要区域的需求驱动因素、法规环境、基础设施能力和战略重点，为市场进入和扩张计划提供资讯。

区域动态显着影响週边血管器材在医疗机构的应用、报销和部署。在美洲，成熟的医疗体系、完善的报销管道和较高的手术量支持新型微创器材的快速普及，而多样化的支付模式和医院整合趋势则要求采用细緻的合约签订方式。相较之下，欧洲、中东和非洲的监管环境差异显着，基础设施也不断变化。欧洲市场通常强调严格的临床证据和集中采购框架，而中东和非洲市场则可能优先考虑与当地临床专长和供应链限制相符的技术。这些差异要求制定适应性强的打入市场策略和有针对性的证据包装，以满足各区域特定的监管和临床需求。

亚太地区的医疗基础设施和发展轨迹呈现出显着的异质性。重点市场对三级医疗中心的快速投资和不断提升的治疗能力，推动了对先进支架系统和可扩展导管解决方案的需求。然而，不同的监管管道、在地化生产奖励以及成本敏感性，要求製造商精心製定定价和在地化策略。在各个地区，医疗系统的共同优先事项——缩短住院时间、提高手术效率和降低併发症率——是器械开发商可以透过实证产品声明和客製化临床支援计画来解决的普遍问题。最终，结合严谨的临床数据、监管专业知识和营运伙伴关係的差异化区域策略，全部区域实现永续应用至关重要。

主要企业，着重介绍竞争定位、关键创新领域、伙伴关係动态以及设备製造商和服务供应商的策略要务。

週边血管器械领域的主要企业透过不断改进器械和平台层面的创新来提升手术效率和改善患者的长期预后，从而实现差异化竞争。一些企业优先开发模组化系统，以提高与现有导管和影像平台的兼容性；而另一些企业则专注于材料科学的突破，以优化输送性能血管再阻塞。随着器械製造商寻求提供能够简化临床医生工作流程并支持术中决策的整合式手术解决方案，他们与影像处理或数位医疗服务提供者之间的策略联盟正变得越来越普遍。此外，与契约製造製造商或本地生产基地合作有助于确保供应链的灵活性，并降低贸易中断带来的风险。

竞争优势也取决于企业如何看待临床证据和健保报销支援。投资于务实的临床试验设计、註册合作以及卫生经济学文件的企业，更有能力向支付者和机构买家证明其价值。对于创新者和规模较小的新参与企业，许可协议、联合开发联盟以及与医疗系统的定向合作，既能帮助企业扩大规模，又能共用研发风险。在这种竞争环境下，成功的企业既要兼顾短期商业性执行，又要对产品系列进行长期投资，以因应临床实务和监管环境的变化。

为产业领导者提供切实可行的建议，以优先考虑可持续成长的投资、协调临床证据策略并优化供应链韧性。

首先，我们优先开展临床证据项目，这些项目既关注短期治疗效果，也关注以患者为中心的长期终点。我们透过设计可操作的研究和註册登记，并将其与常规诊疗路径无缝衔接，从而加快临床医生接受新疗法的步伐，并支持与支付方的互动。其次，我们在开发新设备时注重模组化和互通性，以减少临床医生培训的阻力，并提高其与现有手术室的整合率。第三，我们透过提高供应链透明度和实现采购多元化，最大限度地降低关税和物流瓶颈造成的成本波动风险。透过将部分零件的生产外包到海外，并与供应商建立冗余关係，我们能够在保持生产连续性的同时，优化落地成本。

第四，根据当地监管和报销政策的细微差别调整打入市场策略，确保区域性的证据包装和定价框架能够反映临床优先事项和支付方的阈值。第五，制定临床医生的价值提案，其中不仅包括设备性能，还包括培训、手术支援和结果追踪功能。最后，与影像和数位医疗服务提供者建立策略伙伴关係，以产生能够增强术中决策、支援产品应用和报销的真实世界证据。透过将主导商业化与营运韧性和合作伙伴关係相结合，行业领导者可以应对复杂的市场环境，并实现持续的临床和商业性影响。

透明的调查方法解释了证据来源、分析框架和检验步骤，这些都为报告的见解和建议提供了支持。

调查方法结合了对临床、监管和商业相关人员的访谈，以及对同行评审文献、监管文件和公开临床註册资料的广泛二次分析。一手研究包括与介入性心臟病专家、血管外科医生、采购负责人以及器械和契约製造的高阶主管进行结构化对话，以了解实际营运中的限制和策略重点。二次研究则整合了器械附加檔、临床试验註册资料、监管指导文件和已发表的疗效研究，以检验性能特征和手术趋势。

分析框架整合了跨装置类别、技术类型、材料配置、临床适应症、患者人口统计特征和医疗环境的細項分析。这些框架有助于进行横断面比较，并识别影响产品采纳的价值驱动因素。检验步骤包括将主要访谈结果与次要证据进行交叉比对、对主题结论进行敏感性检验，以及与临床专家进行同行评审，以确保临床结论的准确性和有效性。这种严谨的方法确保了建议得到多方面证据的支持，并反映了影响临床和商业性受众决策的实际考虑。

简洁扼要的结论，综合阐述了对相关人员的影响，并为不断发展的周边血管器械生态系统制定了策略重点。

週边血管介入器材领域正经历快速的手术技术革新、材料创新和不断变化的经济奖励，这要求製造商和医疗系统采取灵活且以实证医学为导向的策略。临床实务正朝着微创方向发展，许多适应症的治疗也更加重视器械在简化的手术流程中保持稳定的效能。同时，监管机构和付款方的期望也促使人们更加重视上市后监测和基于结果的证据，凸显了长期资料收集和价值论证的重要性。

为了取得成功，相关人员必须将设备创新与可操作的临床证据和稳健的营运模式结合。这需要投资于可互通的技术，制定针对特定地区的市场推广计划，并加强能够抵御政策和物流衝击的供应链。最终，能够将临床差异化与临床医生、患者和支付方的明确价值联繫起来的公司，将在复杂多变的市场环境中占据更有利的地位，并获得市场认可。随着产业的发展，这些策略重点应指南近期战术性决策和长期投资组合。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 增加药物涂层球囊在降低周边动脉疾病血管再阻塞的应用
  • 将人工智慧整合到成像系统中以增强週边血管介入治疗规划
  • 增加生物可吸收支架的使用，以最大限度地减少长期週边血管併发症
  • 微导管技术的进步改善了在复杂週边血管系统中的导航。
  • 对下肢床边评估的可携式血管超音波设备的需求不断增长
  • 用于精确清除週边动脉斑块的动脉粥状硬化切除装置的创新
  • 扩大远端医疗远距监测解决方案在术后週边血管患者的应用

第六章美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 週边血管器械市场（依产品分类）

  • 气球充气装置
  • 导管
    • 长週边静脉导管
    • 中线导管
    • 短週边静脉导管
  • 移植
    • 生物移植
    • ePTFE 接枝
    • 聚酯接骨
  • 导管导引线
  • 下腔静脉滤器
  • 介绍人
  • 斑块修饰装置
  • 支架
    • 球囊扩张支架
    • 自膨式支架
  • 血管闭合装置

9. 依技术类型分類的周边血管器材市场

  • 微创手术
    • 血管成形术
    • 支架置入术
  • 开放性手术
    • 心臟绕道手术
    • 切除术

第十章 依材料类型的周边血管器械市场

  • 金属装置
    • 钴铬
    • 镍钛诺
    • 防锈的
  • 非金属装置
    • 聚合物
    • 硅

第十一章 週边血管器械市场（依适应症划分）

  • 功能性週边血管疾病
    • 慢性静脉功能不全
    • 雷诺氏症
    • 静脉曲张
  • 阻塞性週边血管疾病
    • 动脉硬化
    • 血栓闭塞性脉管炎
    • 颈动脉疾病
    • 深层静脉栓塞症
    • 淋巴水肿

12. 依患者类型分類的周边血管器械市场

  • 成年人和老年人
    • 急性疾病
    • 慢性病
  • 孩子们
    • 后天疾病
    • 先天性疾病

第十三章 週边血管器械市场（依最终用户划分）

  • 门诊手术中心
  • 诊所
  • 医院

14. 週边血管器械市场（按地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 週边血管器械市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 各国週边血管器材市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Abbott Laboratories
    • AngioDynamics, Inc.
    • Argon Medical Devices, Inc.
    • ASAHI INTECC CO., LTD
    • B. Braun SE
    • Baxter International Inc.
    • Becton, Dickinson and Company
    • BIOTRONIK SE & Co. KG
    • Boston Scientific Corporation
    • Cardinal Health, Inc.
    • Cook Group Incorporated
    • Esaote SpA
    • FUJIFILM Holdings Corporation
    • GE HealthCare
    • Kimal PLC
    • Koninklijke Philips NV
    • Lepu Medical Technology（Beijing）Co., Ltd.
    • Medtronic PLC
    • Merit Medical Systems, Inc.
    • Nipro Corporation
    • Penumbra, Inc.
    • Sahajanand Medical Technologies Limited
    • Shockwave Medical, Inc. by Johnson & Johnson Services, Inc.
    • Siemens Healthineers AG
    • Summa Therapeutics, LLC
    • Teleflex Incorporated
    • Terumo Corporation
    • WL Gore & Associates, Inc.
Product Code: MRR-374DB5A063C3

The Peripheral Vascular Devices Market is projected to grow by USD 23.72 billion at a CAGR of 6.19% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 14.66 billion
Estimated Year [2025] USD 15.50 billion
Forecast Year [2032] USD 23.72 billion
CAGR (%) 6.19%

A focused introduction that frames opportunities and challenges across clinical practice, device innovation, and health systems management

The peripheral vascular devices landscape sits at the intersection of aging demographics, shifting disease burden, and accelerating procedural innovation. Clinicians increasingly rely on a spectrum of devices that span minimally invasive catheter-based therapies to open surgical grafts, and this procedural diversification has elevated the need for integrated clinical pathways that optimize patient outcomes while controlling costs. As a result, hospital systems and ambulatory surgical centers are re-evaluating formularies, device adoption criteria, and inventory strategies to balance efficacy with reproducibility in routine vascular interventions.

Concurrent regulatory evolution is redefining evidence thresholds and post-market surveillance expectations, prompting manufacturers to invest earlier in robust clinical data and to design iterative devices with lifecycle considerations. From a payer perspective, value-based reimbursement constructs and shifting procedure settings are creating new incentives to prioritize devices that demonstrably reduce readmissions, procedural complications, and time to functional recovery. Taken together, these drivers place a premium on cross-disciplinary collaboration among clinical leaders, device developers, and health system purchasers to translate innovation into scalable care delivery improvements.

Looking ahead, companies that harmonize clinical evidence, manufacturing agility, and reimbursement intelligence will capture the strategic advantage required to meet both clinician preferences and institutional procurement standards.

A comprehensive view of transformative shifts altering clinical practice, technology adoption, and competitive dynamics across peripheral vascular care

The clinical environment for peripheral vascular devices is undergoing several concurrent shifts that are reshaping adoption patterns and competitive positioning. Minimally invasive techniques continue to expand into patient cohorts previously treated with open surgery, driven by refinements in catheter design, plaque modification technologies, and stent materials. This trend has been enabled by improvements in intraprocedural imaging and navigation, which increase procedural precision and broaden the indications suitable for endovascular approaches. As clinicians and health systems favor less invasive pathways that shorten recovery and reduce hospitalization, manufacturers must emphasize ease-of-use, cross-compatibility, and robust clinical outcomes when designing next-generation solutions.

In parallel, material science advances are prompting renewed attention to long-term biocompatibility and device durability. The shift toward nitinol and cobalt chromium alloys in select classes, along with polymer-based coatings and hybrid materials, reflects a drive to optimize radial strength, deliverability, and endothelialization profiles. Regulatory frameworks and payers are increasingly scrutinizing safety signals and real-world performance, which compels device makers to integrate post-market evidence generation into product strategies. Furthermore, supply chain resilience and localized manufacturing investments are becoming strategic priorities as stakeholders seek to mitigate disruption risks while improving lead times and inventory visibility.

Taken together, these transformative shifts underscore the importance of an evidence-centered commercialization approach that aligns clinical utility with scalable manufacturing and distribution models.

An analytical exploration of how the United States tariffs implemented in 2025 are influencing supply chain configurations, sourcing strategies, and commercial operations for device manufacturers

The tariff adjustments introduced in the United States in 2025 have prompted device manufacturers and distributors to reassess global sourcing footprints and contract manufacturing partnerships. While tariffs target specific input categories and finished goods, the broader consequence has been accelerated evaluation of nearshoring opportunities, dual-sourcing provisions, and vertical integration of critical component production. Manufacturers are increasingly modeling total landed costs that account for tariffs, freight volatility, and inventory carrying expenses to inform supplier selection and capital investment decisions. As a result, device developers are prioritizing supplier relationships that offer geographic diversification, quality consistency, and built-in flexibility to scale production in response to demand fluctuations.

Regulatory registration timelines and import compliance considerations are also shaping how firms approach market entry. Companies that rely on multinational supply chains must negotiate additional administrative complexity and potential lead-time extension, particularly for devices with complex multi-component assemblies. Consequently, procurement teams are revisiting contractual terms, adding tariff contingency clauses, and intensifying collaboration with customs and trade compliance experts to preserve margin integrity. For smaller innovators, the tariff environment has increased the comparative attractiveness of licensing agreements or strategic alliances with established manufacturers that already operate compliant, diversified supply chains.

In sum, the 2025 tariff landscape has catalyzed a pragmatic pivot toward resilience and cost transparency, incentivizing investments in supply chain visibility, alternative sourcing, and manufacturing strategies that better absorb trade policy volatility.

A detailed synthesis of segmentation insights across product classes, procedural technologies, materials, clinical indications, patient cohorts, and end-user settings to inform targeted commercialization strategies

Product-level heterogeneity defines how clinical and procurement stakeholders evaluate peripheral vascular offerings. The market spans balloon inflation devices, a variety of catheter types, grafts, guidewires, inferior vena cava filters, introducers, plaque modification devices, stents, and vascular closure systems. Within catheters, distinctions among long peripheral intravenous catheters, midline catheters, and short peripheral intravenous catheters influence procedural selection, inventory management, and clinician training priorities. Graft choices reflect material and biological considerations, with biological grafts, expanded polytetrafluoroethylene constructions, and polyester grafts each presenting unique handling characteristics and long-term performance trade-offs. Stent technologies further bifurcate into balloon-expandable and self-expanding designs, which clinicians select based on lesion morphology, vessel sizing, and deliverability requirements.

Technology type segmentation contrasts minimally invasive surgeries with open surgical approaches. Minimally invasive pathways, particularly angioplasty and stenting, prioritize device deliverability, imaging compatibility, and adjunctive tools for plaque modification. Conversely, open surgical interventions such as bypass procedures and endarterectomy necessitate robust graft options, perfusion considerations, and specialized instrumentation. Material differentiation between metal devices and non-metal devices drives choices around radial strength, fatigue resistance, and biocompatibility; metal device subtypes include cobalt chromium, nitinol, and stainless steel, while non-metal alternatives encompass polymers and silicone-based solutions with evolving coating technologies.

Clinical indication and patient-type segmentation also shape commercial priorities. Indications span functional peripheral vascular disease-encompassing chronic venous insufficiency, Raynaud's disease, and varicose veins-and occlusive pathology including atherosclerosis, Buerger's disease, carotid artery disease, deep vein thrombosis, and lymphedema. Patient categories include adult and geriatric cohorts differentiated by acute versus chronic conditions, as well as pediatric populations with acquired or congenital conditions. End-user settings such as ambulatory surgical centers, outpatient clinics, and hospitals each impose different procurement cycles, regulatory oversight, and clinician proficiency expectations. Integrating these segmentation lenses enables companies to align product design, clinical evidence generation, and go-to-market models with the needs of targeted clinical pathways and institutional purchasers

Regional insights that elucidate demand drivers, regulatory environments, infrastructure capacity, and strategic priorities across major global geographies to inform market entry and expansion plans

Regional dynamics materially influence how peripheral vascular devices are adopted, reimbursed, and diffused across care settings. In the Americas, mature healthcare systems, established reimbursement pathways, and high procedure volumes support rapid adoption of novel minimally invasive devices, while divergent payer models and hospital consolidation trends require nuanced contracting approaches. In contrast, Europe, the Middle East and Africa present a mosaic of regulatory heterogeneity and variable infrastructure. European markets often emphasize rigorous clinical evidence and centralized procurement frameworks, whereas Middle Eastern and African markets may prioritize technology that aligns with local clinical expertise and supply chain constraints. These differences necessitate adaptive market access strategies and targeted evidence packages to meet region-specific regulatory and clinical expectations.

The Asia-Pacific region exhibits pronounced heterogeneity in healthcare infrastructure and growth trajectories. Rapid investments in tertiary care centers and increasing procedural capacity in key markets are driving demand for both advanced stent systems and scalable catheter solutions. However, divergent regulatory pathways, local manufacturing incentives, and cost sensitivity require manufacturers to calibrate pricing and localization strategies carefully. Across all regions, health system priorities such as reducing hospital length of stay, improving procedural throughput, and minimizing complication rates serve as universal levers that device developers can address through evidence-based product claims and tailored clinical support programs. Ultimately, a differentiated regional approach that combines rigorous clinical data, regulatory expertise, and operational partnerships will be essential to achieving sustainable adoption across these geographies

Key company insights highlighting competitive positioning, innovation focus areas, partnership dynamics, and strategic imperatives for device manufacturers and service providers

Leading companies in the peripheral vascular device domain are differentiating through a combination of incremental device improvements and platform-level innovations that address procedural efficiency and long-term patient outcomes. Some firms are prioritizing modular systems that enhance cross-compatibility with existing catheter and imaging platforms, whereas others concentrate on material science breakthroughs to optimize deliverability and reduce restenosis. Strategic alliances between device manufacturers and imaging or digital health providers are becoming more common as companies seek to deliver integrated procedural solutions that streamline clinician workflows and support intraoperative decision-making. In addition, partnerships with contract manufacturers and localized production hubs help secure supply chain flexibility and reduce exposure to trade-related disruptions.

Competitive differentiation also hinges on how companies approach clinical evidence and reimbursement support. Firms that invest in pragmatic trial designs, registry partnerships, and health economics dossiers are better positioned to demonstrate value to payers and institutional buyers. For innovators and smaller entrants, licensing agreements, co-development alliances, and targeted collaborations with health systems provide pathways to scale while sharing development risk. Across the competitive landscape, successful players balance near-term commercial execution with longer-term investments in product portfolios that anticipate shifts in clinical practice and regulatory expectations

Actionable recommendations that equip industry leaders to prioritize investments, align clinical evidence strategies, and optimize supply chain resilience for sustained growth

First, prioritize clinical evidence programs that address both short-term procedural outcomes and longer-term patient-centric endpoints. Designing pragmatic studies and registries that integrate seamlessly with routine care pathways will accelerate clinician acceptance and support payer conversations. Second, invest in modularity and interoperability when developing new devices to reduce clinician training friction and increase the likelihood of integration into existing procedural suites. Third, strengthen supply chain visibility and diversify sourcing to minimize exposure to tariff-driven cost fluctuations and logistical bottlenecks. Nearshoring certain components and cultivating redundant supplier relationships can preserve production continuity while optimizing landed costs.

Fourth, tailor market access strategies to regional regulatory and reimbursement nuances, ensuring that localized evidence packages and pricing frameworks reflect clinical priorities and payer thresholds. Fifth, develop clinician-facing value propositions that extend beyond device performance to include training, procedural support, and outcomes-tracking capabilities. Finally, pursue strategic partnerships with imaging and digital health providers to enhance intraoperative decision-making and to generate real-world evidence that supports adoption and reimbursement. By combining evidence-led commercialization with operational resilience and collaborative partnerships, industry leaders can better navigate market complexity and drive sustained clinical and commercial impact

A transparent research methodology explaining the evidence sources, analytic frameworks, and validation steps that underpin the insights and recommendations in the report

The research methodology combines primary interviews with clinical, regulatory, and commercial stakeholders and extensive secondary analysis of peer-reviewed literature, regulatory filings, and publicly available clinical registries. Primary engagements include structured conversations with interventional cardiologists, vascular surgeons, procurement leaders, and senior executives from device firms and contract manufacturers to capture real-world operational constraints and strategic priorities. Secondary research synthesizes device labeling, clinical trial registries, regulatory guidance documents, and published outcomes studies to triangulate performance characteristics and procedural trends.

Analytic frameworks incorporate segmentation analysis across device class, technology type, material composition, clinical indication, patient demographics, and care setting. These frameworks drive cross-sectional comparisons and enable identification of value drivers that influence adoption. Validation steps include cross-referencing primary interview findings with secondary evidence, performing sensitivity checks on thematic conclusions, and conducting peer reviews with clinical experts to ensure the accuracy and relevance of clinical assertions. This rigorous approach ensures that recommendations are grounded in multiple evidence streams and reflect the practical considerations that shape decision-making across clinical and commercial audiences

A concise conclusion that synthesizes implications for stakeholders and frames strategic priorities for the evolving peripheral vascular device ecosystem

The peripheral vascular device environment is characterized by rapid procedural evolution, material innovation, and shifting economic incentives that collectively demand agile, evidence-centered strategies from manufacturers and health systems alike. Clinical pathways are trending toward less invasive approaches in many indications, which places a premium on devices that deliver consistent performance with streamlined procedural workflows. Simultaneously, regulatory and payer expectations are driving deeper commitments to post-market surveillance and outcomes-based evidence, reinforcing the importance of long-term data collection and value demonstration.

To succeed, stakeholders must harmonize device innovation with pragmatic clinical evidence and resilient operational models. This entails investing in interoperable technologies, targeting regionally tailored market access plans, and fortifying supply chains to withstand policy and logistical shocks. Ultimately, companies that can translate clinical differentiation into clear value for clinicians, patients, and payers will be best positioned to capture adoption in a complex and rapidly changing landscape. These strategic priorities should guide near-term tactical decisions and longer-term portfolio investments as the industry moves forward

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increasing adoption of drug-coated balloons to reduce restenosis in peripheral artery disease
  • 5.2. Integration of artificial intelligence in imaging systems to enhance peripheral vascular intervention planning
  • 5.3. Rising use of bioresorbable scaffolds to minimize long-term complications in peripheral vessels
  • 5.4. Advancements in microcatheter technology to improve navigation through complex peripheral vasculature
  • 5.5. Growing demand for portable vascular ultrasound devices for point-of-care lower limb assessments
  • 5.6. Innovations in atherectomy devices for precise removal of peripheral arterial plaque
  • 5.7. Expansion of telehealth remote monitoring solutions for post-procedural peripheral vascular patients

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Peripheral Vascular Devices Market, by Product

  • 8.1. Balloon Inflation Devices
  • 8.2. Catheters
    • 8.2.1. Long Peripheral Intravenous Catheters
    • 8.2.2. Midline Catheters
    • 8.2.3. Short Peripheral Intravenous Catheter
  • 8.3. Grafts
    • 8.3.1. Biological Grafts
    • 8.3.2. ePTFE Grafts
    • 8.3.3. Polyester Grafts
  • 8.4. Guidewires
  • 8.5. Inferior Vena Cava Filters
  • 8.6. Introducers
  • 8.7. Plaque Modification Devices
  • 8.8. Stents
    • 8.8.1. Balloon-Expandable Stents
    • 8.8.2. Self-Expanding Stents
  • 8.9. Vascular Closure Devices

9. Peripheral Vascular Devices Market, by Technology Type

  • 9.1. Minimally Invasive Surgeries
    • 9.1.1. Angioplasty
    • 9.1.2. Stenting
  • 9.2. Open Surgery
    • 9.2.1. Bypass Surgery
    • 9.2.2. Endarterectomy

10. Peripheral Vascular Devices Market, by Material Type

  • 10.1. Metal Devices
    • 10.1.1. Cobalt Chromium
    • 10.1.2. Nitinol
    • 10.1.3. Stainless Steel
  • 10.2. Non-Metal Devices
    • 10.2.1. Polymer
    • 10.2.2. Silicone

11. Peripheral Vascular Devices Market, by Indication

  • 11.1. Functional Peripheral Vascular Disease
    • 11.1.1. Chronic Venous Insufficiency
    • 11.1.2. Raynaud's Disease
    • 11.1.3. Varicose Veins
  • 11.2. Occlusive Peripheral Vascular Disease
    • 11.2.1. Atherosclerosis
    • 11.2.2. Buerger's Disease
    • 11.2.3. Carotid Artery Disease
    • 11.2.4. Deep Vein Thrombosis
    • 11.2.5. Lymphedema

12. Peripheral Vascular Devices Market, by Patient Types

  • 12.1. Adult & Geriatric
    • 12.1.1. Acute Conditions
    • 12.1.2. Chronic Conditions
  • 12.2. Pediatric
    • 12.2.1. Acquired Conditions
    • 12.2.2. Congenital Conditions

13. Peripheral Vascular Devices Market, by End-User

  • 13.1. Ambulatory Surgical Centers
  • 13.2. Clinics
  • 13.3. Hospitals

14. Peripheral Vascular Devices Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Peripheral Vascular Devices Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Peripheral Vascular Devices Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Abbott Laboratories
    • 17.3.2. AngioDynamics, Inc.
    • 17.3.3. Argon Medical Devices, Inc.
    • 17.3.4. ASAHI INTECC CO., LTD
    • 17.3.5. B. Braun SE
    • 17.3.6. Baxter International Inc.
    • 17.3.7. Becton, Dickinson and Company
    • 17.3.8. BIOTRONIK SE & Co. KG
    • 17.3.9. Boston Scientific Corporation
    • 17.3.10. Cardinal Health, Inc.
    • 17.3.11. Cook Group Incorporated
    • 17.3.12. Esaote S.p.A.
    • 17.3.13. FUJIFILM Holdings Corporation
    • 17.3.14. GE HealthCare
    • 17.3.15. Kimal PLC
    • 17.3.16. Koninklijke Philips N.V.
    • 17.3.17. Lepu Medical Technology (Beijing) Co., Ltd.
    • 17.3.18. Medtronic PLC
    • 17.3.19. Merit Medical Systems, Inc.
    • 17.3.20. Nipro Corporation
    • 17.3.21. Penumbra, Inc.
    • 17.3.22. Sahajanand Medical Technologies Limited
    • 17.3.23. Shockwave Medical, Inc. by Johnson & Johnson Services, Inc.
    • 17.3.24. Siemens Healthineers AG
    • 17.3.25. Summa Therapeutics, LLC
    • 17.3.26. Teleflex Incorporated
    • 17.3.27. Terumo Corporation
    • 17.3.28. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. PERIPHERAL VASCULAR DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. PERIPHERAL VASCULAR DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. PERIPHERAL VASCULAR DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BALLOON INFLATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BALLOON INFLATION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BALLOON INFLATION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BALLOON INFLATION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BALLOON INFLATION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BALLOON INFLATION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY LONG PERIPHERAL INTRAVENOUS CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY LONG PERIPHERAL INTRAVENOUS CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY LONG PERIPHERAL INTRAVENOUS CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY LONG PERIPHERAL INTRAVENOUS CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY LONG PERIPHERAL INTRAVENOUS CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY LONG PERIPHERAL INTRAVENOUS CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MIDLINE CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MIDLINE CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MIDLINE CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MIDLINE CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MIDLINE CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MIDLINE CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SHORT PERIPHERAL INTRAVENOUS CATHETER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SHORT PERIPHERAL INTRAVENOUS CATHETER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SHORT PERIPHERAL INTRAVENOUS CATHETER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SHORT PERIPHERAL INTRAVENOUS CATHETER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SHORT PERIPHERAL INTRAVENOUS CATHETER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SHORT PERIPHERAL INTRAVENOUS CATHETER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BIOLOGICAL GRAFTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BIOLOGICAL GRAFTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BIOLOGICAL GRAFTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BIOLOGICAL GRAFTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BIOLOGICAL GRAFTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BIOLOGICAL GRAFTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY EPTFE GRAFTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY EPTFE GRAFTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY EPTFE GRAFTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY EPTFE GRAFTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY EPTFE GRAFTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY EPTFE GRAFTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY POLYESTER GRAFTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY POLYESTER GRAFTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY POLYESTER GRAFTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY POLYESTER GRAFTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY POLYESTER GRAFTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY POLYESTER GRAFTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GUIDEWIRES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GUIDEWIRES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GUIDEWIRES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GUIDEWIRES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GUIDEWIRES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INFERIOR VENA CAVA FILTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INFERIOR VENA CAVA FILTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INFERIOR VENA CAVA FILTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INFERIOR VENA CAVA FILTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INFERIOR VENA CAVA FILTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INFERIOR VENA CAVA FILTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INTRODUCERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INTRODUCERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INTRODUCERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INTRODUCERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INTRODUCERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INTRODUCERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PLAQUE MODIFICATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PLAQUE MODIFICATION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PLAQUE MODIFICATION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PLAQUE MODIFICATION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PLAQUE MODIFICATION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PLAQUE MODIFICATION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BALLOON-EXPANDABLE STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BALLOON-EXPANDABLE STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BALLOON-EXPANDABLE STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BALLOON-EXPANDABLE STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BALLOON-EXPANDABLE STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BALLOON-EXPANDABLE STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SELF-EXPANDING STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SELF-EXPANDING STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SELF-EXPANDING STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SELF-EXPANDING STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SELF-EXPANDING STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SELF-EXPANDING STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ANGIOPLASTY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ANGIOPLASTY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ANGIOPLASTY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ANGIOPLASTY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ANGIOPLASTY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ANGIOPLASTY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BYPASS SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BYPASS SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BYPASS SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BYPASS SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BYPASS SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BYPASS SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ENDARTERECTOMY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ENDARTERECTOMY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ENDARTERECTOMY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ENDARTERECTOMY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ENDARTERECTOMY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ENDARTERECTOMY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COBALT CHROMIUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COBALT CHROMIUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COBALT CHROMIUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COBALT CHROMIUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COBALT CHROMIUM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COBALT CHROMIUM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NITINOL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NITINOL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NITINOL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NITINOL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NITINOL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NITINOL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY POLYMER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY POLYMER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY POLYMER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY POLYMER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY POLYMER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY POLYMER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SILICONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SILICONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SILICONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SILICONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SILICONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CHRONIC VENOUS INSUFFICIENCY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CHRONIC VENOUS INSUFFICIENCY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CHRONIC VENOUS INSUFFICIENCY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CHRONIC VENOUS INSUFFICIENCY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CHRONIC VENOUS INSUFFICIENCY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CHRONIC VENOUS INSUFFICIENCY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY RAYNAUD'S DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY RAYNAUD'S DISEASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY RAYNAUD'S DISEASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY RAYNAUD'S DISEASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY RAYNAUD'S DISEASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY RAYNAUD'S DISEASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY VARICOSE VEINS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY VARICOSE VEINS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY VARICOSE VEINS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY VARICOSE VEINS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY VARICOSE VEINS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY VARICOSE VEINS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ATHEROSCLEROSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ATHEROSCLEROSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ATHEROSCLEROSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ATHEROSCLEROSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ATHEROSCLEROSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ATHEROSCLEROSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BUERGER'S DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BUERGER'S DISEASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BUERGER'S DISEASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BUERGER'S DISEASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BUERGER'S DISEASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BUERGER'S DISEASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CAROTID ARTERY DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CAROTID ARTERY DISEASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CAROTID ARTERY DISEASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CAROTID ARTERY DISEASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CAROTID ARTERY DISEASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CAROTID ARTERY DISEASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY LYMPHEDEMA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY LYMPHEDEMA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY LYMPHEDEMA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY LYMPHEDEMA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY LYMPHEDEMA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY LYMPHEDEMA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ACUTE CONDITIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ACUTE CONDITIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ACUTE CONDITIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ACUTE CONDITIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ACUTE CONDITIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ACUTE CONDITIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL PERIPHERAL VASCU